Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Theratechnologies Inc
T.TH
Alternate Symbol(s):
THTX
Healthcare
Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs...
in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jul 24, 2024 4:17pm
RE:RE:Hard to believe
Or.. sell the HIV franchise for 3 times sales and repay Marathon loan. And buy a decent P2 onco compound and create some noise around it. Something creative and gutsy... but that won't
...more
(30)
•••
muslix1
X
View Profile
View Bullboard History
Comment by
muslix1
on Jul 24, 2024 3:51pm
RE:RE:Hard to believe
Nothing happens as usual at the end of July... it's the construction holidays in Quebec ... everyone is at the chalet ( Magog or Tremblant)...Lol
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jul 24, 2024 10:21am
RE:Hard to believe
We are stuck at zero already..... you forget it and hope they can pay the dept and spare some value for the legacy shareholders with some creative acquisition or by getting recognition for their onco
...more
(26)
•••
Bucknelly21
X
View Profile
View Bullboard History
Post by
Bucknelly21
on Jul 24, 2024 9:48am
Hard to believe
Pretty wild you guys have hung on this long and still nothing on the pipeline I applaud your loyalty....
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jul 17, 2024 1:16pm
RE:Tesamorelin's therapeutic benefits for naive HIV patients
These studies keeps them busy with grants but never deliver anything for th shareholders. Interesting once again and another step for the advancement of science. Should celebrate it on
...more
(197)
•••
scarlet1967
X
View Profile
View Bullboard History
Post by
scarlet1967
on Jul 16, 2024 8:06pm
Tesamorelin's therapeutic benefits for naive HIV patients
This is a recent study( Drs. Grinspoon, Fourman and Lindsay which all have been involved with numerous research projects related to Tesamorelin are among authors!) highlighting Tesamorelin's
...more
(41)
•••
juniper88
X
View Profile
View Bullboard History
Comment by
juniper88
on Jul 15, 2024 8:28am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Murky sales report imo
I kinda take everything that management says with a grain of salt. As I wrote earlier, the next couple of quarter will either confirm or deny what they are saying now. My instinct says
...more
(200)
•••
palinc2000
X
View Profile
View Bullboard History
Comment by
palinc2000
on Jul 15, 2024 6:26am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Murky sales report imo
You are right but how could the new nornal base sales be 16.2million? Connecting the dots to make 16.2 Million is where I have difficulty.... We will know in October when 3 rd
...more
(41)
•••
juniper88
X
View Profile
View Bullboard History
Comment by
juniper88
on Jul 14, 2024 9:13am
RE:RE:RE:RE:RE:RE:RE:RE:RE:Murky sales report imo
So, if the new normal quarterly sales base was $16.2 million last quarter then Q3 could be $17 million and Q4 $17.8 million. If Trogazo sale don't go down then Q3 and Q4 revenue could be
...more
(200)
•••
palinc2000
X
View Profile
View Bullboard History
Comment by
palinc2000
on Jul 13, 2024 12:26pm
RE:RE:RE:RE:RE:RE:RE:RE:Murky sales report imo
Dubuc during the last CC For the second quarter of fiscal 2024, net sales of EGRIFTA SV reached $16.2 million compared to $10.9 million in Q2 of last year, which represents a 49% increase
...more
(200)
•••
palinc2000
X
View Profile
View Bullboard History
Comment by
palinc2000
on Jul 12, 2024 12:48pm
RE:RE:RE:RE:RE:RE:RE:Murky sales report imo
I meant math and assumptions.. I took Egrifta historical revenues and trend to make a wild guess May be others can offer better inputs
(41)
•••
juniper88
X
View Profile
View Bullboard History
Comment by
juniper88
on Jul 12, 2024 9:53am
RE:RE:RE:RE:RE:RE:Murky sales report imo
The math is simple, I don't believe anyone needs to check it. The question is are the inputs into the equation correct? How did you come up with how much inventory restocking
...more
(200)
•••
palinc2000
X
View Profile
View Bullboard History
Comment by
palinc2000
on Jul 11, 2024 1:23pm
RE:RE:RE:RE:RE:Murky sales report imo
If you exclude the inventory restocking in the 2 nd quarter sales to patients in the 2 nd quarter were probably no more than 12 millions for Egrifta Assuming Trog sales are flat at 6 million
...more
(43)
•••
SPCEO1
X
View Profile
View Bullboard History
Comment by
SPCEO1
on Jul 11, 2024 11:21am
RE:RE:RE:RE:Murky sales report imo
It would be amazing if they were able to maintain sales at the $22 million level seen in the 2Q as Palin suggested following the benefit from the inventory restocking. Also, they need to average $24.3
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >